Sartorius AG (SRT3d)
FRA • Healthcare
July 10, 2026 at 15:30 UTC
About Sartorius AG
Sartorius AG trades on XETRA as SRT3.DE and makes laboratory and bioprocess tools for healthcare and life sciences customers. Its portfolio spans instruments, consumables, and related services used from research through manufacturing and quality testing, and it recorded EUR 3.5 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Sartorius AG's Technical Indicators Summary
| Indicator | Value |
|---|---|
RSI (14) | 59.86 |
Stochastic %K (14, 3, 3) | 74.75 |
CCI (20) | 182.09 |
WPR (14) | -12.95 |
Momentum (10) | 18.00 |
MFI | 76.28 |
MACD Level (12, 26) | 1.22 |
Bollinger Bands | $210.28 - $241.29 |
ATR (14) | $9.68 (4.00%) |
ADX (14) | 11.51 |
OBV | 1,509,035 |
VWAP | $242.13 |
Classic Pivot Point | $228.53 |
Fibonacci Pivot Point | $228.53 |
Simple Moving Averages | $224.65 - $230.82(5 indicators) |
Exponential Moving Averages | $224.58 - $230.43(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
SRT3d closed 3.77% above yesterday’s level of 233.30. End-of-day sector performance was slightly negative (-0.66%), mildly offsetting stock-specific strength. Berenberg reiterates its Buy rating on SRT3d, per Marketscreener.
Trading Volume
Below avg (81.7K)
76K
vs S&P 500 Today
Strong Outperformance
+3.73%
52-Week Position
Upper range
72.1%
Updated: July 10, 2026 at 15:12 UTC